Gene expression profiling of human hepatoblastoma using archived formalin-fixed and paraffin-embedded tissues

Virchows Archiv

Volumn 458, Issue 4, 2011, Pages 453-465

  Shin, Eun ^a   Lee, Kyoung Bun ^a   Park, Soo Young ^a   Kim, Soo Hee ^a   Ryu, Han Suk ^a   Park, Young Nyun ^b   Yu, Eunsil ^c   Jang, Ja June ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

DASL chip assay; Hepatoblastoma; Prognosis; YY1

Indexed keywords

COMPLEMENTARY DNA; FORMALDEHYDE; PARAFFIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR YY1;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; BIRC5 GENE; CELL ADHESION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; GENE; GENE EXPRESSION; GENETIC ANALYSIS; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYCN GENE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FORMALDEHYDE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARAFFIN EMBEDDING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

EID: 79956217495     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1043-8     Document Type: Article

References (31)

1. Roebuck DJ, Perilongo G (2006) Hepatoblastoma: an oncological review. Pediatr Radiol 36:183-186
2. Schnater JM, Kohler SE, Lamers WH, von Schweinitz D, Aronson DC (2003) Where do we stand with hepatoblastoma? A review. Cancer 98:668-678 (Pubitemid 36959261)
3. Hu J, Wills M, Baker BA, Perlman EJ (2000) Comparative genomic hybridization analysis of hepatoblastomas. Genes Chromosom Cancer 27:196-201
4. Weber RG, Pietsch T, von Schweinitz D, Lichter P (2000) Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome. Am J Pathol 157:571-578 (Pubitemid 30627562)
5. Curia MC, Zuckermann M, De Lellis L, Catalano T, Lattanzio R, Aceto G, Veschi S, Cama A, Otte JB, Piantelli M, Mariani-Costantini R, Cetta F, Battista P (2008) Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations. Mod Pathol 21:7-14
6. Jeng YM, Wu MZ, Mao TL, Chang MH, Hsu HC (2000) Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. Cancer Lett 152:45-51
7. Akmal SN, Yun K, MacLay J, Higami Y, Ikeda T (1995) Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma. Hum Pathol 26:846-851
8. Gray SG, Eriksson T, Ekstrom C, Holm S, von Schweinitz D, Kogner P, Sandstedt B, Pietsch T, Ekstrom TJ (2000) Altered expression of members of the IGF-axis in hepatoblastomas. Br J Cancer 82:1561-1567 (Pubitemid 30204363)
9. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531-537
10. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406:747-752
11. Boyer J, Allen WL, McLean EG, Wilson PM, McCulla A, Moore S, Longley DB, Caldas C, Johnston PG (2006) Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer. Cancer Res 66:2765-2777
12. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412:822-826 (Pubitemid 32801464)
13. Nagata T, Takahashi Y, Ishii Y, Asai S, Nishida Y, Murata A, Koshinaga T, Fukuzawa M, Hamazaki M, Asami K, Ito E, Ikeda H, Takamatsu H, Koike K, Kikuta A, Kuroiwa M, Watanabe A, Kosaka Y, Fujita H, Miyake M, Mugishima H (2003) Transcriptional profiling in hepatoblastomas using high-density oligonucleotide DNA array. Cancer Genet Cytogenet 145:152-160 (Pubitemid 36993747)
14. Luo JH, Ren B, Keryanov S, Tseng GC, Rao UN, Monga SP, Strom S, Demetris AJ, Nalesnik M, Yu YP, Ranganathan S, Michalopoulos GK (2006) Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44:1012-1024 (Pubitemid 46489565)
15. Yamada S, Ohira M, Horie H, Ando K, Takayasu H, Suzuki Y, Sugano S, Hirata T, Goto T, Matsunaga T, Hiyama E, Hayashi Y, Ando H, Suita S, Kaneko M, Sasaki F, Hashizume K, Ohnuma N, Nakagawara A (2004) Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Oncogene 23:5901-5911 (Pubitemid 39093534)
16. Bibikova M, Talantov D, Chudin E, Yeakley JM, Chen J, Doucet D, Wickham E, Atkins D, Barker D, Chee M, Wang Y, Fan JB (2004) Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol 165:1799-1807 (Pubitemid 39435177)
17. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR (2008) Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359:1995-2004
18. Fan JB, Yeakley JM, Bibikova M, Chudin E, Wickham E, Chen J, Doucet D, Rigault P, Zhang B, Shen R, McBride C, Li HR, Fu XD, Oliphant A, Barker DL, Chee MS (2004) A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res 14:878-885 (Pubitemid 38660505)
19. Fan JB, Oliphant A, Shen R, Kermani BG, Garcia F, Gunderson KL, Hansen M, Steemers F, Butler SL, Deloukas P, Galver L, Hunt S, McBride C, Bibikova M, Rubano T, Chen J, Wickham E, Doucet D, Chang W, Campbell D, Zhang B, Kruglyak S, Bentley D, Haas J, Rigault P, Zhou L, Stuelpnagel J, Chee MS (2003) Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol 68:69-78
20. Schwab M (2004) MYCN in neuronal tumours. Cancer Lett 204:179-187
21. Mertens F, Mandahl N, Mitelman F, Heim S (1994) Cytogenetic analysis in the examination of solid tumors in children. Pediatr Hematol Oncol 11:361-377 (Pubitemid 24226972)
22. Morgenstern DA, Anderson J (2006) MYCN deregulation as a potential target for novel therapies in rhabdomyosarcoma. Expert Rev Anticancer Ther 6:217-224 (Pubitemid 44192933)
23. Tsuda H, Shimosato Y, Upton MP, Yokota J, Terada M, Ohira M, Sugimura T, Hirohashi S (1988) Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation. Lab Invest 59:321-327
24. Mares J, Polanska V, Gorgens H, Sedlacek Z, Marikova T, Bocek P, Kodet R, Schackert J, Goetz P (1998) Oncogene amplification and expression in pediatric solid tumors. Neoplasma 45:123-127 (Pubitemid 28335675)
25. Fest S, Huebener N, Bleeke M, Durmus T, Stermann A, Woehler A, Baykan B, Zenclussen AC, Michalsky E, Jaeger IS, Preissner R, Hohn O, Weixler S, Gaedicke G, Lode HN (2009) Survivin minigene DNA vaccination is effective against neuroblastoma. Int J Cancer 125:104-114
26. Eckerle I, Muth D, Batzler J, Henrich KO, Lutz W, Fischer M, Witt O, Schwab M, Westermann F (2009) Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma. Cancer Lett 285:99-107
27. Yoshida R, Ogata T, Masawa N, Nagai T (2008) Hepatoblastoma in a Noonan syndrome patient with a PTPN11 mutation. Pediatr Blood Cancer 50:1274-1276 (Pubitemid 351555559)
28. Adesina AM, Lopez-Terrada D, Wong KK, Gunaratne P, Nguyen Y, Pulliam J, Margolin J, Finegold MJ (2009) Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways. Hum Pathol 40:843-853
29. LeRoith D, Roberts CT Jr (2003) The insulin-like growth factor system and cancer. Cancer Lett 195:127-137 (Pubitemid 36588961)
30. Braconi C, Bracci R, Bearzi I, Bianchi F, Sabato S, Mandolesi A, Belvederesi L, Cascinu S, Valeri N, Cellerino R (2008) Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients. Ann Oncol 19:1293-1298 (Pubitemid 351911960)
31. Gordon S, Akopyan G, Garban H, Bonavida B (2006) Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 25:1125-1142